TY  - CONF

T1  - Prophylactic Ruxolitinib for Cytokine Release Syndrome (CRS) in Relapse/Refractory (R/R) AML Patients Treated with Flotetuzumab

JO  - Blood

UR  - https://doi.org/10.1182/blood-2020-134612

PY  - 2020/11/05

AU  - Uy GL

AU  - Rettig MP

AU  - Christ S

AU  - Aldoss I

AU  - Byrne MT

AU  - Erba HP

AU  - Arellano ML

AU  - Foster MC

AU  - Godwin JE

AU  - Ravandi F

AU  - Sayre PH et al

ED  - 

DO  - DOI: 10.1182/blood-2020-134612

PB  - American Society of Hematology

VL  - 136

IS  - Supplement 1

SP  - 19

EP  - 21

Y2  - 2026/02/25

ER  -